Explore the scientific frontier of identifying drugs that block SARS-CoV-2 entry, offering a powerful tool against current and future variants.
Explore the scientific advances in SARS-CoV-2 therapeutic targets and drug development, from viral structure to cutting-edge treatments.
Discover how O-tert-butyl-threonine modification creates potent SARS-CoV-2 main protease inhibitors with enhanced cellular potency and antiviral effectiveness.